Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis

Background: Prurigo nodularis (PN) is a complex to manage heterogenous disease with limited available treatments. Patients with PN are usually older, with multiple comorbidities adding to the complexity of their care, frequently having failed to control symptoms with other treatments.Objective: The...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Brian S. Kim, Shawn G. Kwatra, Gil Yosipovitch, Sonja Ständer, Sarina B. Elmariah, Martin Metz, Tsen-Fang Tsai, Hiroyuki Murota, Xing-Hua Gao, H. Chih-ho Hong, Ashish Bansal, Melanie Makhija, Ryan B. Thomas, Donia Bahloul, Joseph Zahn, Simmi Wiggins
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Taylor & Francis Group 2026-12-01
Цуврал:	Journal of Dermatological Treatment
Нөхцлүүд:	Prurigo nodularis dupilumab treatment
Онлайн хандалт:	https://www.tandfonline.com/doi/10.1080/09546634.2026.2626213
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!